VI
NARI

Versor Investments’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Versor Investments’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,600
Closed -$643K – 985
2024
Q4 		$643K Buy
12,600
+3,000
+31% +$147K 0.11% 293
2024
Q3 		$396K Buy
+9,600
New +$461K 0.06% 493
2023
Q3 		– Sell
-4,132
Closed -$240K – 863
2023
Q2 		$240K Sell
4,132
-5,723
-58% -$361K 0.04% 503
2023
Q1 		$608K Buy
9,855
+3,046
+45% +$183K 0.08% 251
2022
Q4 		$433K Buy
+6,809
New +$494K 0.04% 390

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

Versor Investments's NARI Position: Q1 2025 in Review

Versor Investments sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 12,600 shares — an estimated $643K sold.

Versor Investments first reported a position in NARI in Q4 2022 and held it in 5 quarters. The position peaked at $643K in Q4 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Versor Investments reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Versor Investments sold 12,600 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $643K.
  • Versor Investments first reported a position in Inari Medical, Inc. Common Stock in Q4 2022 and held it in 5 quarters.
  • Versor Investments's Inari Medical, Inc. Common Stock position peaked at $643K in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Versor Investments's 13F filing for Q1 2025, filed 13 May 2025.